In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Exelixis (EXEL – Research Report). The ...
Barclays analyst Peter Lawson raised the firm’s price target on Exelixis (EXEL) to $29 from $25 and keeps an Equal Weight rating on the shares ...